104 related articles for article (PubMed ID: 10987178)
1. Immunohistochemically visualized localisation of gangliosides Glac2 (GD3) and Gtri2 (GD2) in cells of human intracranial tumors.
Mennel HD; Bosslet K; Geissel H; Bauer BL
Exp Toxicol Pathol; 2000 Aug; 52(4):277-85. PubMed ID: 10987178
[TBL] [Abstract][Full Text] [Related]
2. Expression of GD2-epitopes in human intracranial tumors and normal brain.
Mennel HD; Bosslet K; Wiegandt H; Sedlacek HH; Bauer BL; Rodden AF
Exp Toxicol Pathol; 1992 Oct; 44(6):317-24. PubMed ID: 1280497
[TBL] [Abstract][Full Text] [Related]
3. Ganglioside (GD2) expression and intermediary filaments in astrocytic tumors.
Mennel HD; Lell B
Clin Neuropathol; 2005; 24(1):13-8. PubMed ID: 15696779
[TBL] [Abstract][Full Text] [Related]
4. Gangliosides in meningiomas: correlation of Glac2 to intermediary filament.
Pausch G; Jennemann R; Mennel HD; Bauer BL; Rodden AF; Wiegandt H
Acta Neurochir (Wien); 1992; 117(3-4):166-71. PubMed ID: 1414518
[TBL] [Abstract][Full Text] [Related]
5. Two human monoclonal antibodies reacting with the major gangliosides of human melanomas and comparison with corresponding mouse monoclonal antibodies.
Furukawa K; Yamaguchi H; Oettgen HF; Old LJ; Lloyd KO
Cancer Res; 1989 Jan; 49(1):191-6. PubMed ID: 2908845
[TBL] [Abstract][Full Text] [Related]
6. [Expression of gangliosides on malignant melanoma].
Kageshita T; Nakamura T; Hirai S; Arao T
Nihon Hifuka Gakkai Zasshi; 1990 May; 100(6):689-94. PubMed ID: 2120484
[TBL] [Abstract][Full Text] [Related]
7. Biosynthesis and expression of the disialoganglioside GD2, a relevant target antigen on small cell lung carcinoma for monoclonal antibody-mediated cytolysis.
Cheresh DA; Rosenberg J; Mujoo K; Hirschowitz L; Reisfeld RA
Cancer Res; 1986 Oct; 46(10):5112-8. PubMed ID: 3019521
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody-defined correlations in melanoma between levels of GD2 and GD3 antigens and antibody-mediated cytotoxicity.
Thurin J; Thurin M; Kimoto Y; Herlyn M; Lubeck MD; Elder DE; Smereczynska M; Karlsson KA; Clark WM; Steplewski Z
Cancer Res; 1987 Mar; 47(5):1229-33. PubMed ID: 3815333
[TBL] [Abstract][Full Text] [Related]
9. Detection of glioma-associated gangliosides GM2, GD2, GD3, 3'-isoLM1 3',6'-isoLD1 in central nervous system tumors in vitro and in vivo using epitope-defined monoclonal antibodies.
Wikstrand CJ; Fredman P; Svennerholm L; Bigner DD
Prog Brain Res; 1994; 101():213-23. PubMed ID: 7518092
[TBL] [Abstract][Full Text] [Related]
10. Incorporation, remodeling and re-expression of exogenous gangliosides in human cancer cell lines in vitro and in vivo.
Nishio M; Furukawa K
Nagoya J Med Sci; 2004 May; 67(1-2):35-44. PubMed ID: 15279066
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies to the inhibitor of apoptosis protein survivin in patients with brain tumors.
Söling A; Plugge EM; Schmitz M; Weigle B; Jacob R; Illert J; Holzhausen HJ; Rainov NG
Int J Oncol; 2007 Jan; 30(1):123-8. PubMed ID: 17143520
[TBL] [Abstract][Full Text] [Related]
12. Ganglioside composition and its relation to clinical data in brain tumors.
Shinoura N; Dohi T; Kondo T; Yoshioka M; Takakura K; Oshima M
Neurosurgery; 1992 Sep; 31(3):541-9. PubMed ID: 1407435
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies to malignant human gliomas.
Wikstrand CJ; Fredman P; Svennerholm L; Humphrey PA; Bigner SH; Bigner DD
Mol Chem Neuropathol; 1992 Oct; 17(2):137-46. PubMed ID: 1384525
[TBL] [Abstract][Full Text] [Related]
14. Morphological, immunocytochemical and flow cytometric in vitro characterisation of a surface-adherent medulloblastoma.
Parker K; Pilkington GJ
Anticancer Res; 2005; 25(6B):3855-63. PubMed ID: 16309171
[TBL] [Abstract][Full Text] [Related]
15. Human gliosarcoma-associated ganglioside composition is complex and distinctive as evidenced by high-performance mass spectrometric determination and structural characterization.
Vukelić Z; Kalanj-Bognar S; Froesch M; Bîndila L; Radić B; Allen M; Peter-Katalinić J; Zamfir AD
Glycobiology; 2007 May; 17(5):504-15. PubMed ID: 17293353
[TBL] [Abstract][Full Text] [Related]
16. Antidesmosomal monoclonal antibody in the diagnosis of intracranial tumours.
Parrish EP; Steart PV; Garrod DR; Weller RO
J Pathol; 1987 Nov; 153(3):265-73. PubMed ID: 3323433
[TBL] [Abstract][Full Text] [Related]
17. A human glioma cell line retaining expression of GFAP and gangliosides, recognized by A2B5 and LB1 antibodies, after prolonged passage.
Knott JC; Edwards AJ; Gullan RW; Clarke TM; Pilkington GJ
Neuropathol Appl Neurobiol; 1990 Dec; 16(6):489-500. PubMed ID: 1982895
[TBL] [Abstract][Full Text] [Related]
18. Oncotargets GD2 and GD3 are highly expressed in sarcomas of children, adolescents, and young adults.
Dobrenkov K; Ostrovnaya I; Gu J; Cheung IY; Cheung NK
Pediatr Blood Cancer; 2016 Oct; 63(10):1780-5. PubMed ID: 27304202
[TBL] [Abstract][Full Text] [Related]
19. Detection of GD3 ganglioside in primary melanomas depends on histopathologic procedures used for tumor preservation.
Debarbieux S; Popa I; Thomas L; Kanitakis J; Pirot F; Portoukalian J; Haftek M
Acta Dermatovenerol Croat; 2009; 17(3):209-16. PubMed ID: 19818222
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of malignant properties of human glioma cells by ganglioside GD3/GD2.
Iwasawa T; Zhang P; Ohkawa Y; Momota H; Wakabayashi T; Ohmi Y; Bhuiyan RH; Furukawa K; Furukawa K
Int J Oncol; 2018 Apr; 52(4):1255-1266. PubMed ID: 29436609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
